| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 22.56B | 22.46B | 16.09B | 15.04B | 9.90B |
| Gross Profit | 2.98B | 4.99B | 123.99M | 2.24B | 815.85M |
| EBITDA | 1.54B | 4.13B | -428.60M | 2.39B | 336.95M |
| Net Income | 1.40B | 4.10B | -1.77B | 992.87M | -3.61B |
Balance Sheet | |||||
| Total Assets | 23.46B | 23.06B | 18.93B | 19.30B | 15.77B |
| Cash, Cash Equivalents and Short-Term Investments | 4.79B | 5.23B | 2.60B | 4.06B | 2.51B |
| Total Debt | 5.83B | 6.98B | 8.59B | 9.06B | 8.09B |
| Total Liabilities | 14.53B | 14.47B | 15.08B | 14.24B | 11.64B |
| Stockholders Equity | 8.86B | 8.48B | 3.95B | 5.58B | 4.86B |
Cash Flow | |||||
| Free Cash Flow | 973.81M | 4.39B | -566.01M | 780.11M | -2.93B |
| Operating Cash Flow | 2.68B | 5.36B | 738.74M | 2.21B | 165.26M |
| Investing Cash Flow | -1.13B | -1.56B | -689.45M | -1.25B | -1.76B |
| Financing Cash Flow | -1.69B | -1.86B | -344.26M | 89.01M | 1.45B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$1.57B | 1.96 | 10.09% | ― | 13.78% | 432.26% | |
62 Neutral | $20.33B | 14.63 | -3.31% | 3.23% | 1.93% | -12.26% | |
59 Neutral | HK$594.70M | 88.79 | 0.88% | 1.88% | -10.60% | ― | |
55 Neutral | HK$12.15B | -10.36 | -23.27% | 0.86% | -2.69% | -695.87% | |
54 Neutral | HK$18.44B | -42.17 | -3.91% | ― | 3.07% | -64.23% | |
53 Neutral | HK$2.85B | -7.07 | 0.82% | 0.69% | -7.11% | ― | |
48 Neutral | HK$10.72B | 17.54 | 15.66% | 1.33% | ― | ― |